Menu
Home
About
Our Mission
Our Team
Science
CAR-γδ T Cell
iPSC-γδ NKT Cell
Publications
Pipeline
Manufacturer
Investors
Stock Info
Press Releases
Contact Us
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
«
Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers
Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy
»